Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 19.43%43.87M | 10.57%43.4M | -2.03%37.26M | -4.21%153.88M | -4.27%39.71M | -6.67%36.73M | 0.31%39.25M | -6.53%38.03M | 7.82%160.65M | 4.82%41.48M |
| Cost of revenue | 12.42%18.99M | 11.04%19.05M | -4.17%16.55M | -6.35%69.8M | -5.52%17.08M | -5.95%16.89M | 1.10%17.15M | -0.25%17.27M | 14.07%74.53M | 10.83%18.08M |
| Gross profit | 25.40%24.88M | 10.21%24.36M | -0.25%20.71M | -2.37%84.09M | -3.31%22.63M | -7.27%19.84M | -0.28%22.1M | -11.18%20.76M | 2.93%86.12M | 0.60%23.4M |
| Operating expense | -4.40%15.9M | 29.27%17.23M | -15.64%13.88M | 23.58%56.09M | 14.18%11.08M | 14.66%16.63M | 18.34%13.33M | 16.37%16.45M | 142.12%45.39M | 144.59%9.7M |
| Selling and administrative expenses | -0.84%16.61M | 31.79%17.8M | -2.96%16.12M | 9.42%60.78M | -10.86%15.33M | 10.98%16.75M | 4.61%13.5M | 14.05%16.62M | -2.32%55.55M | 23.07%17.19M |
| -General and administrative expense | -0.84%16.61M | 31.79%17.8M | -2.96%16.12M | 9.42%60.78M | -10.86%15.33M | 10.98%16.75M | 4.61%13.5M | 14.05%16.62M | -2.32%55.55M | 23.07%17.19M |
| Other operating expenses | ---- | -90.00%5K | ---- | -88.61%9K | ---- | -5.08%56K | -9.09%50K | -3.85%50K | -99.75%79K | ---- |
| Total other operating income | 315.29%706K | 151.97%577K | 939.81%2.25M | -54.07%4.7M | -43.28%4.25M | -73.56%170K | -86.56%229K | -55.46%216K | -85.40%10.24M | -88.84%7.49M |
| Operating profit | 179.84%8.98M | -18.73%7.13M | 58.48%6.83M | -31.27%28M | -15.69%11.55M | -53.43%3.21M | -19.52%8.78M | -53.34%4.31M | -37.26%40.73M | -69.56%13.7M |
| Net non-operating interest income (expenses) | -8.35%-1.42M | -16.65%-1.44M | 30.40%-1.36M | 28.91%-5.79M | 67.01%-1.3M | -141.40%-1.31M | 38.30%-1.23M | -16.52%-1.95M | 33.53%-8.14M | 33.64%-3.93M |
| Non-operating interest expense | 8.35%1.42M | 16.65%1.44M | -30.40%1.36M | -28.91%5.79M | -67.01%1.3M | 141.40%1.31M | -38.30%1.23M | 16.52%1.95M | -33.53%8.14M | -33.64%3.93M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -72.86%630K | 1.46M | -84.06%448K | 1,105.72%5.45M | 205.00%504K | 6,926.47%2.32M | 0 | 10,139.29%2.81M | 95.00%-542K | 96.19%-480K |
| Less:Other special charges | ---- | ---- | ---- | ---1.79M | ---- | ---- | ---- | ---1.79M | ---- | ---- |
| Less:Write off | 72.86%-630K | ---1.46M | 55.99%-448K | -774.91%-3.66M | -205.00%-504K | -6,926.47%-2.32M | --0 | -3,735.71%-1.02M | -95.00%542K | -96.19%480K |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 94.01%8.2M | -5.21%7.15M | 14.54%5.92M | -13.71%27.66M | 15.76%10.76M | -33.12%4.22M | -15.31%7.55M | -31.39%5.17M | -23.37%32.05M | -64.92%9.3M |
| Income tax | 39.23%3.43M | -1.85%2.76M | -1.21%2.29M | -14.18%10.87M | 17.04%3.46M | -9.84%2.47M | -25.55%2.81M | -27.44%2.32M | 4.08%12.66M | -36.53%2.96M |
| Net income | 170.78%4.76M | -7.20%4.4M | 27.39%3.62M | -13.39%16.79M | 15.16%7.3M | -50.89%1.76M | -7.79%4.74M | -34.32%2.84M | -34.63%19.39M | -70.98%6.34M |
| Net income continuous operations | 170.78%4.76M | -7.20%4.4M | 27.39%3.62M | -13.39%16.79M | 15.16%7.3M | -50.89%1.76M | -7.79%4.74M | -34.32%2.84M | -34.63%19.39M | -70.98%6.34M |
| Noncontrolling interests | 160.85%4.35M | -10.36%4.13M | 28.72%3.49M | -15.27%14.01M | 34.14%5.07M | -53.13%1.67M | -5.87%4.61M | -36.90%2.71M | 1.40%16.53M | -29.63%3.78M |
| Net income attributable to the company | 352.75%412K | 103.82%267K | 0.00%132K | -2.55%2.79M | -12.89%2.23M | 295.65%91K | -46.31%131K | 312.50%132K | -78.60%2.86M | -84.46%2.56M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 352.75%412K | 103.82%267K | 0.00%132K | -2.55%2.79M | -12.89%2.23M | 295.65%91K | -46.31%131K | 312.50%132K | -78.60%2.86M | -84.46%2.56M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 355.56%0.0041 | 107.69%0.0027 | 0.00%0.0013 | -2.45%0.0279 | -12.89%0.0223 | 350.00%0.0009 | -45.83%0.0013 | 333.33%0.0013 | -78.59%0.0286 | -84.47%0.0256 |
| Diluted earnings per share | 355.56%0.0041 | 107.69%0.0027 | 0.00%0.0013 | -2.45%0.0279 | -12.89%0.0223 | 350.00%0.0009 | -45.83%0.0013 | 333.33%0.0013 | -78.59%0.0286 | -84.47%0.0256 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.